OSLO, Norway--(BUSINESS WIRE)--OncoImmunity has become the first company to obtain a CE-IVD mark for the clinical use of a machine-learning based neoantigen prediction technology. This quality ...

DUBLIN--(BUSINESS WIRE)--The "IVD Test Procedure Volumes, 2019-2024" report has been added to ResearchAndMarkets.com's offering. In vitro diagnostic (IVD) test volumes are the gold standard for ...